| Habitat |
It is found in Nepal.
|
 |
 |
| Morphology
Description (Habit) |
It is an
erect, glabrous, spinescent shrub with obovate to elliptic,
subacute to obtuse, entire or toothed leaves. The flowers
are yellow and in corymbose racemes. The fruits are
oblong-ovoid or ovoid, bright red berries.
|
|
 |
 |
|
| Principal
Constituents |
The alkaloids in
the bark and root bark of Berberis aristata are berberine, berbamine,
aromoline, karachine, palmatine, oxyacanthine and oxyberberine1.
|
 |
|
| Pharmacology |
|
Berberone hydrochloride, an alkaloid isolated from Berberis
aristata, was found to have significant anti-inflammatory activity
on acute, subacute and chronic types of inflammations produced by
immunological and non-immunological methods2. Chronic
oral (20mg./kg.) and intramuscular (2mg./kg.) administration of
Berberine sulphate to rats increased the duration of pentobarbitone-induced
sleeping time and decreased serum cholesterol levels3.
The preventive and curative effects of Berberis aristata fruit
extract on paracetamol- and CCl4-induced hepatotoxicity
was studied. Pre-treatment of mice with the (Berberis aristata
fruits), crude extract of Berberis aristata fruits (500mg/kg),
reduced the death rate to 10 percent. Pre-treatment of rats with the
fruit extract (500mg/kg, orally twice daily for 2 days) prevented (p
less than 0.05) the paracetamol-(640mg/kg) as well as
CCl4-(1.5ml/kg)-induced rise in serum transaminases (GOT and GPT).
Post-treatment with three successive doses of the extract (500
mg/kg, 6h) restricted the hepatic damage induced by acetaminophen (p
less than 0.01) but CCl4-induced hepatotoxicity was not altered. The
plant extract (500mg/kg) caused significant prolongation in
pentobarbital (75mg/kg)-induced sleep as well as increased
strychnine-induced lethality in mice suggestive of inhibitory effect
on microsomal drug metabolizing enzymes (MDME). Hepatoprotective
action of the crude extract of Berberis aristata fruits partly
through MDME inhibitory action has been indicated4.
|
 |
 |
 |
| Clinical
Studies |
Clinical studies with berberine
were conducted in 356 patients of Cholera and compared with 264
patients treated with chloramphenicol. Berberine was found to be
effective in both bacteriologically positive and negative patients.
It reduced the mortality rate, volume and duration of diarrhea, the
intake of intravenous fluid and the convalescence period. Berberine
was found to be better than chloramphenicol in this respect5.
Twenty five patients of giardiasis were treated with berberine in a
dose of 5mg./kg./day for six days, and the results compared with
those of metronidazole given in a dose of 10mg./kg/day for six days
in 9 patients. Twenty patients receiving vitamin B complex syrup for
6 days served as controls. Twelve patients receiving berberine, 3
receiving metronidazole and 3 receiving vitamin B complex showed
relief of clinical symptoms. The stools became free of giardia in 17
patients receiving metronidazole and 5 receiving B complex6.
Berberine was found to be effective in controlling gastroenteritis
in 50 children. It is a good anti diarrhoeal agent and could be
easily administered in children in the form of a palatable
suspension. The drug was free from any serious toxicity7.
|
 |
| Toxicity |
LD50 value of berberine sulphate
in mice, intraperitonially, was found to be 24.3mg./kg.
|
 |
| Indications |
The roots form a reputed drug in
Ayurvedic medicine and possess antibacterial and anti-inflammatory
activities. The drug is regarded as a bitter tonic and is apparently
used as a cholagogue, stomachic, laxative, diaphoretic, antipyretic
and antiseptic. It is administered externally in painful eye
affections, indolent ulcers and hemorrhoids. The rootbark is very
useful in periodic neuralgia and menorrhagia.
|
Confidentiality
&
Disclaimer
© ECOTECH TECHNOLOGIES (I) PVT. LTD.
|